Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Apple Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $4.67T | |
|---|---|---|
| Revenue (ttm) | 466.8B | |
| Net income (ttm) | 128.9B | |
| EPS (ttm) | $8.72 | |
| Shares out | 14.6B | |
| P/E (trailing) | 39.4x | |
| P/E (forward) | 33.6x | |
| Dividend | $1.08 (0.31%) | |
| Volume | 20,920,297 | |
| Beta | 1.07 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-09-25 | 2022-09-24 | 2023-09-30 | 2024-09-28 | 2025-09-27 | Trend |
| Revenue | $365.82B | $394.33B | $383.29B | $391.04B | $416.16B | +3.3% |
| Gross profit | $152.84B | $170.78B | $169.15B | $180.68B | $195.20B | +6.3% |
| Operating income | $108.95B | $119.44B | $114.30B | $123.22B | $133.05B | +5.1% |
| Net income | $94.68B | $99.80B | $97.00B | $93.74B | $112.01B | +4.3% |
| EPS (diluted) | $5.61 | $6.11 | $6.13 | $6.08 | $7.46 | +7.4% |
| EBITDA | $123.14B | $130.54B | $125.82B | $134.66B | $144.43B | +4.1% |
| R&D | $21.91B | $26.25B | $29.92B | $31.37B | $34.55B | +12.1% |
| SG&A | $21.97B | $25.09B | $24.93B | $26.10B | $27.60B | +5.9% |
Recent company headlines from major financial publishers.
The Base path assumes near-term demand converts, followed by slower mature growth. Sustained stronger growth or a material undershoot would disconfirm that path.
This scenario requires improved availability to convert demand into revenue and continued share reduction to support earnings per share. It fails if FY2027 revenue growth falls below 8%, or if diluted shares stop falling.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 6.9% | $251 | $263 | $278 | $298 | $324 |
| 7.9% | $223 | $231 | $240 | $251 | $266 |
| 8.9% | $203 | $208 | $214 | $221 | $230 |
| 9.9% | $187 | $191 | $195 | $200 | $206 |
| 10.9% | $175 | $177 | $181 | $184 | $188 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
